Esoteric Testing Market Size, Share, By Type (Immunology Testing, Genetic Testing, Oncology Test, Neurology Testing, Infectious Disease Testing and Others), By Technology (ELISA, Chemiluminescence Immunoassay, Mass Spectrometry, Flow Cytometry, and Others

Esoteric Testing Market Size, Share, By Type (Immunology Testing, Genetic Testing, Oncology Test, Neurology Testing, Infectious Disease Testing and Others), By Technology (ELISA, Chemiluminescence Immunoassay, Mass Spectrometry, Flow Cytometry, and Others), By End User (Hospital, Independent and Reference Laboratories) and By Region - Trends, Analysis and Forecast till 2034

Esoteric testing market is driven by the increasing geriatric population, an increase in drug and alcohol abuse, and strong laws for drug and alcohol testing. In addition, increasing awareness regarding the use of diagnostics tests is another factor propelling the growth of the global market. Furthermore, technological advancements in esoteric tests for personalized medicine, increasing funding in Rthe & D sector, and many others are also anticipated to create opportunities for growth of the global market over the forecast period.

Esoteric Testing Market Report Highlights:

• The esoteric testing market size was worth USD 18.62 billion in 2023.
• The market is expected to reach USD 53.6 billion by 2034 at a CAGR of 12.3%
• North America held the largest share of the market in 2024.
• Asia Pacific is projected to be the fastest-growing market in the coming years.
• By type, infectious disease testing dominates the target market growth.
• By technology, chemiluminescence immunoassay holds the largest share of the target market.
• By end user, independent and reference laboratories are expected to dominate the target market growth.

Esoteric Testing Market Key Highlights:

North America: This region is expected to dominate the growth of the market during forecast period due to increasing cases of chronic diseases, rising diagnostic tests, technological advancements in esoteric testing, and among other factors.

Asia Pacific: This region is considered to be the fastest growing region in the target market due to increasing patients of chronic diseases, government policies and strategies for diagnostics, increasing demand for ELISA and RT-PCR, and rising awareness for self-diagnostic testing.

Latest Acquisition:

Bruker Completes the acquisition of Molecular Diagnostics Pioneer ELITech in May 2024. ELITech is a unique, rapidly expanding, and lucrative supplier of assays and systems for microbiology, biomedical systems/specialty IVD and molecular diagnostics (MDx). ELITech MDx assay portfolio with an emphasis on testing for exotic infectious diseases. For molecular testing in mid-sized hospitals, ELITech provides the InGenius and BeGenius sample-to-answer (S2A) systems, which are completely automated and patented. Europe and the Americas are ELITech's primary regions for R&D, manufacturing, and business.

Browse ∼52 market data tables and ∼46 figures through ∼188 slides and in-depth TOC on “Esoteric Testing Market Size, Share, By Type (Immunology Testing, Genetic Testing, Oncology Test, Neurology Testing, Infectious Disease Testing, and Others), By Technology (ELISA, Chemiluminescence Immunoassay, Mass Spectrometry, Flow Cytometry, and Others), By End-User (Hospital and Independent and Reference Laboratories) and By Region - Trends, Analysis and Forecast till 2034”

Esoteric Testing Market Competitive Landscape:

The key players operating in the esoteric testing market include Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, OPKO Health, Inc., Sonic Healthcare USA, H. U. Group Holdings, Inc., Kindstar Globalgene Technology, Inc., Stanford Health Care, Mayo Foundation for Medical Education and Research (MFMER), ARUP Laboratories, Athena Esoterix, LLC., ACM Global Laboratories, and Eurofins Scientific.